Location
burgos
Posted
June 15, 2026
Commute
Local Area
Local Opportunity Near You!
This job is in your area. Enjoy a short commute and work close to home.
Job Description
Company Overview
Antes de solicitar este puesto, por favor, lea la siguiente información sobre esta oportunidad que encontrará a continuación.
Cheiron is a Stanford-based AI company building the AI-native operating system for drug development.
Biopharma knowledge work is structurally fragmented. Critical decisions depend on stitching together evidence across literature, clinical trials, regulatory precedent, and patents—spread across disconnected systems. Cheiron replaces this paradigm with a unified intelligence layer: our proprietary Lifesciences Knowledge Graph (LKG), which integrates and structures these data sources into a single, continuously evolving system of record.
On top of this foundation, Cheiron deploys workflow-native AI agents that execute real-world R&D, clinical, and regulatory tasks end-to-end—with full traceability and scientific rigor.
Since launching in 2024, Cheiron has achieved rapid global adoption. In Korea, we reached 22% of the bioph...
Antes de solicitar este puesto, por favor, lea la siguiente información sobre esta oportunidad que encontrará a continuación.
Cheiron is a Stanford-based AI company building the AI-native operating system for drug development.
Biopharma knowledge work is structurally fragmented. Critical decisions depend on stitching together evidence across literature, clinical trials, regulatory precedent, and patents—spread across disconnected systems. Cheiron replaces this paradigm with a unified intelligence layer: our proprietary Lifesciences Knowledge Graph (LKG), which integrates and structures these data sources into a single, continuously evolving system of record.
On top of this foundation, Cheiron deploys workflow-native AI agents that execute real-world R&D, clinical, and regulatory tasks end-to-end—with full traceability and scientific rigor.
Since launching in 2024, Cheiron has achieved rapid global adoption. In Korea, we reached 22% of the bioph...